Altius Institute For Biomedical Sciences

TO RADICALLY ENABLE AND ADVANCE BIOMEDICAL DISCOVERY THROUGH THE DEVELOPMENT AND EXPLORATORY APPLICATION OF NEW TECHNOLOGIES AND APPROACHES FOR ILLUMINATING CELL AND TISSUE STATES AND FUNCTION. TO ACHIEVE THIS VISION, ALTIUS IS ESTABLISHING A WHOLLY NEW TYPE OF SCIENTIFIC AND TECHNOLOGICAL DISCOVERY ENVIRONMENT DESIGNED TO FOSTER LEAPS IN INNOVATION. ALTIUS WILL LEVERAGE ITS CUTTING-EDGE TECHNOLOGIES TO SPAN THE CHASM BETWEEN BASIC BIOLOGICAL DISCOVERIES RELATED TO THE FUNCTION OF CELLS AND TISSUES AND THE TRANSLATION OF THESE INSIGHTS INTO THE CLINICAL ARENA AND THE DEVELOPMENT OF NOVEL MEDICINES.

ALTIUS DIRECTLY CONDUCTS AN ACTIVE AND MULTIFACETED PROGRAM OF BASIC SCIENCE RESEARCH IN THE FIELDS OF GENETICS AND BIOTECHNOLOGY. WE CONDUCT THE MAJORITY OF RESEARCH PROGRAMS DIRECTLY IN OUR OWN LABORATORIES LOCATED IN SEATTLE, WASHINGTON, AND ALSO COLLABORATE WITH ACADEMIC RESEARCH HOSPITALS. ALTIUS AIMS TO DISCOVER, DEVELOP, AND TRANSLATE FOR CLINICAL USE DATA AND TRANSFORMATIVE TECHNOLOGIES THAT ILLUMINATE THE CONTROL OF HUMAN GENES IN MEDICALLY IMPORTANT CELL AND TISSUE TYPES. OUR RESEARCH PROGRAMS FOCUS ON GAINING A RICHER UNDERSTANDING OF HUMAN CELLS IN HEALTH AND DISEASE FOR THE PURPOSE OF DEVELOPING NEW APPROACHES TO DIAGNOSING AND TREATING DISEASE. TOWARD THESE GOALS, ALTIUS EMPHASIZES THE DEVELOPMENT, SCALING AND TRANSLATIONAL APPLICATION OF DIVERSE TECHNOLOGY PLATFORMS, INCLUDING GENETIC AND GENOMIC ANALYSES, CELL AND GENOME ENGINEERING, SINGLE MOLECULE DNA AND CHROMATIN ANALYSIS, AND HIGH-RESOLUTION CELL IMAGING. THESE TECHNOLOGIES PROVIDE HIGHLY SENSITIVE WINDOWS INTO CELLULAR RESPONSE TO DISEASE, ENVIRONMENTAL EXPOSURES, AND POTENTIAL THERAPEUTIC AGENTS, AND THEY COLLECTIVELY OPEN NEW DOORS TO THE DISCOVERY OF NEW MEDICINES.IN RESPONSE TO THE PANDEMIC AND RELATED DISASTER DECLARATION, ALTIUS LEVERAGED ITS SCIENTIFIC EXPERTISE TO CREATE AND PROVIDE COVID-19 GENETIC TESTING SERVICES UNDER EMERGENCY CONTRACTS WITH GOVERNMENTAL AGENCIES. THESE SERVICES WERE FUNDED DIRECTLY OR INDIRECTLY BY ONE-TIME EMERGENCY APPROPRIATIONS WITHOUT CHARGE TO END RECIPIENTS. ALTIUS ALSO PROVIDED COVID-19 GENETIC TESTING SERVICES TO LOCAL AND NONPROFIT EDUCATIONAL ORGANIZATIONS. IN ADDITION, ALTIUS UTILIZED DATA DROM ITS GENETIC TESTING TO CONDUCT RESEARCH INTO COVID-19 EPIDEMIOLOGY AND VARIANTS IN COLLABORATION WITH GOVERNMENTAL AGENCIES AND ACADEMIC INSTITUTIONS.